Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

BIO-RAD LABORATORIES, INC. (BIO) Stock Forecast 2025 - AI Price Prediction & Analysis

BIO-RAD LABORATORIES, INC. (BIO) AI Stock Price Forecast & Investment Analysis

BIO-RAD LABORATORIES, INC. Stock Price Chart and Technical Analysis

Loading BIO-RAD LABORATORIES, INC. interactive price chart and technical analysis...

BIO-RAD LABORATORIES, INC. (BIO) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

BIO-RAD LABORATORIES, INC. (Stock Symbol: BIO) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry. The organization employs approximately 8120 professionals worldwide . The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Financial Performance & Key Metrics Analysis

Annual Revenue: $2554 million generating a -3.5% net profit margin .

Market Capitalization: $8204 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -1.0% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for BIO-RAD LABORATORIES, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

BIO-RAD LABORATORIES, INC. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share . The company demonstrates robust operational efficiency through strong free cash flow generation of $459 million annually , complemented by impressive 25.7% year-over-year cash flow growth. The company maintains a healthy 56.8% gross margin, indicating strong pricing power and operational efficiency.

BIO-RAD LABORATORIES, INC. (BIO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for BIO-RAD LABORATORIES, INC. stock analysis.

Loading BIO-RAD LABORATORIES, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into BIO-RAD LABORATORIES, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if BIO-RAD LABORATORIES, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For BIO-RAD LABORATORIES, INC.: With a P/E ratio of 25.70, the market highly values future growth prospects.

P/E Ratio 25.70x
P/B Ratio 1.15x
Market Cap $8204M
EPS $11.09
Book Value/Share $258.36
Revenue/Share $92.58
FCF/Share $12.23
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently BIO-RAD LABORATORIES, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For BIO-RAD LABORATORIES, INC.: An ROE of -1.0% indicates room for improvement in shareholder value creation.

ROE -1.0%
ROA -0.7%
ROIC -0.9%
Gross Margin 56.8%
Operating Margin 18.4%
Net Margin -3.5%
EBT Margin -7.9%
Tax Rate 21.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess BIO-RAD LABORATORIES, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For BIO-RAD LABORATORIES, INC.: A current ratio of 5.10 indicates strong liquidity.

Current Ratio 5.10x
Quick Ratio 3.91x
D/E Ratio 0.13x
Financial Leverage 1.41x
Interest Coverage -43.2x
Working Capital $1508M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal BIO-RAD LABORATORIES, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For BIO-RAD LABORATORIES, INC.: Free cash flow of $459M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $589M
Free Cash Flow $459M
Capital Spending $-130M
OCF Growth YoY 25.7%
FCF Growth YoY 32.6%
FCF/Sales 15.9%
CapEx/Sales 4.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively BIO-RAD LABORATORIES, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For BIO-RAD LABORATORIES, INC.: An asset turnover of 0.20x suggests room for improvement in asset utilization.

Asset Turnover 0.20x
Receivables Turnover 6.6x
Inventory Turnover 2.1x
Fixed Assets Turnover 4.3x
Days Sales Outstanding 55 days
Days Inventory 176 days
Payables Period 44 days
Cash Conversion Cycle 188 days
Understanding Financial Statement Data

What these metrics mean: Key figures from BIO-RAD LABORATORIES, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For BIO-RAD LABORATORIES, INC.: With annual revenue of $2554M, BIO-RAD LABORATORIES, INC. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2554M
R&D Expense $280M
SG&A Expense $29M
Cost of Goods Sold $1177M
Balance Sheet Highlights ($ Millions)
Total Current Assets $23M
Cash & Short-term Investments $14M
Total Liabilities $29M
Short-term Debt $0M
Accounts Receivable $3M
Inventory $4M
Dividend & Shareholder Information
Shares Outstanding 28M
Growth Metrics (YoY)
EPS Growth -10.5%

Latest BIO-RAD LABORATORIES, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting BIO-RAD LABORATORIES, INC. (BIO) stock price and investment outlook.

, source: PE Hub

Bio-Rad Laboratories Inc., a life science research and clinical diagnostics products company, is paying $162 million in cash to acquire venture-backed biotech company QuantaLife.

BIO-RAD LABORATORIES, INC. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of BIO-RAD LABORATORIES, INC. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast $34077M 29.2x 5.6x
AKYA Unlock Forecast $64M -2.1x -10.9x
ASTC Unlock Forecast $8M 28.9x 0.3x
AVTR Unlock Forecast $9009M 13.1x 1.4x
AXDX Unlock Forecast $0M -0.2x 0.0x
BIO Unlock Forecast $8204M 25.7x 1.2x
BIO-B Unlock Forecast $6816M 21.4x 1.0x
BNGO Unlock Forecast $16M 0.0x 0.3x
BRKR Unlock Forecast $6145M 28.3x 3.2x
CTKB Unlock Forecast $530M 82.0x 1.4x
EYPT Unlock Forecast $815M -4.4x 3.3x
HBIO Unlock Forecast $22M -8.3x 1.4x
ILMN Unlock Forecast $15746M 12.5x 7.0x
LAB Unlock Forecast $475M -2.4x 1.1x
LCTC Unlock Forecast $9M x 1.5x
MTD Unlock Forecast $24913M 31.5x -136.9x
NAUT Unlock Forecast $89M -3.8x 0.5x
OMIC Unlock Forecast $50M -1.7x 0.4x
PACB Unlock Forecast $414M -1.5x 6.7x
PRPO Unlock Forecast $22M -1.2x 0.6x
QTRX Unlock Forecast $209M -11.1x 0.7x
RPID Unlock Forecast $123M -0.9x 2.3x
RVTY Unlock Forecast $10954M 38.4x 1.5x
SEER Unlock Forecast $134M -2.0x 0.4x
TXG Unlock Forecast $1777M -8.6x 2.3x
WAT Unlock Forecast $17843M 27.0x 8.3x

Frequently Asked Questions - BIO-RAD LABORATORIES, INC. Stock Forecast

How accurate are BIO-RAD LABORATORIES, INC. stock predictions?

Our AI model demonstrates 64% historical accuracy for BIO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence BIO-RAD LABORATORIES, INC. stock price forecasts?

Our analysis considers BIO-RAD LABORATORIES, INC.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is BIO-RAD LABORATORIES, INC. a good investment in 2025?

Based on our AI analysis, BIO-RAD LABORATORIES, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are BIO-RAD LABORATORIES, INC. forecasts updated?

BIO-RAD LABORATORIES, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced BIO-RAD LABORATORIES, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for BIO-RAD LABORATORIES, INC. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...